Clinical-grade data and AI-driven analytics from a single intraoral biosensor — powering predictive, preventative, and precision health across sleep medicine, sports, and wellness.
t.e.s.a captures clinical-grade biosignals from existing oral appliances and turns them into actionable health intelligence.
A single biosensor integrates into any existing oral appliance — no hardware redesign needed. The device is invisible; the data is transformative.
Five biosensor modalities stream continuous data — during sleep, sport, and daily life — building a rich longitudinal health profile.
AI transforms raw biosignals into clinical-grade intelligence — sleep scores, treatment validation, and actionable insights delivered to patients and providers in real time.
Five biosensor modalities feed a unified analytics platform. Patients sleep comfortably — clinicians get the data they've never had.
Actionable sleep data powering predictive, preventative, precision health for patients, providers, and the sleep medicine industry.
Continuous biosignal analytics identify trends before they become clinical events. t.e.s.a delivers the data to make OAT management proactive, not reactive — and reimbursable via RPM.
Managing OSA reduces the risk of depression, diabetes, cancer, hypertension, and stroke. t.e.s.a gives clinicians the confidence to prescribe OAT with data-backed validation.
Every patient is different. t.e.s.a provides individualized sleep data that enables tailored treatment — comfortable, discreet, and clinically precise.
Managing OSA effectively reduces the risk of serious comorbidities. t.e.s.a provides the data clinicians need to validate treatment outcomes.
t.e.s.a gives manufacturers a complete analytics and cloud layer — turning legacy sleep appliances into connected, AI-driven diagnostic products without building it themselves.
Integrates with any manufacturer's existing appliance. No hardware redesign required. Neutral analytics layer works with any OAT device on the market.
Manufacturers get AI-driven diagnostics and a full cloud platform without 12-18 months of engineering investment or ongoing infrastructure costs.
Legacy sleep appliances become RPM-ready connected devices, creating recurring prescriber revenue that drives product pull-through and differentiates on shelf.
Deep domain expertise in sleep medicine, AI, med-tech, and scaling healthcare startups.
Rob Kibler, Asim Roy, Brandon Canfield and Duane Mancini discuss their work in the sleep monitoring space.
Elio Harmon interviews Asim Roy and Rob Kibler about the challenges of sleep apnea and the future of OAT.
Published research on photoplethysmography-based sleep quality monitoring using intraoral biosensors.
Strategic Partners
